Scadden David (CIK 1707715) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-23). Recent activity: Buy AGIO (2,816 shares), Buy AGIO (200 shares), Sell AGIO (200 shares), Buy AGIO (200 shares), Sell AGIO (200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 2,816 | $0 |
| 2025-11-14 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 200 | $3,618 |
| 2025-11-14 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Sell | 200 | $8,768 |
| 2025-10-10 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 200 | $3,618 |
| 2025-10-10 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Sell | 200 | $8,200 |
| 2025-10-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 200 | $3,618 |
| 2025-10-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Sell | 200 | $8,000 |
| 2025-08-29 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 200 | $3,618 |
| 2025-08-29 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Sell | 200 | $8,000 |
| 2025-07-15 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 1,400 | $25,326 |
| 2025-07-15 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Sell | 1,400 | $56,000 |
| 2025-06-23 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | Buy | 2,120 | $0 |
Source: SEC Form 4 filings · as of 2026-06-23